Modalis Therapeutics Corporation
4883.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | ¥4,704,962 | ¥3,839,784 | ¥9,750,909 | ¥17,625,396 |
| - Cash | ¥3,575,277 | ¥1,883,437 | ¥2,933,162 | ¥4,936,193 |
| + Debt | ¥0 | ¥412,500 | ¥0 | ¥0 |
| Enterprise Value | ¥1,129,685 | ¥2,368,847 | ¥6,817,747 | ¥12,689,203 |
| Revenue | ¥0 | ¥0 | ¥40,500 | ¥1,100 |
| % Growth | – | -100% | 3,581.8% | – |
| Gross Profit | ¥0 | -¥731 | -¥83,175 | ¥1,100 |
| % Margin | – | – | -205.4% | 100% |
| EBITDA | -¥2,146,919 | -¥2,373,923 | -¥2,583,356 | -¥667,547 |
| % Margin | – | – | -6,378.7% | -60,686.1% |
| Net Income | -¥1,317,894 | -¥2,391,821 | -¥2,702,709 | -¥738,956 |
| % Margin | – | – | -6,673.4% | -67,177.8% |
| EPS Diluted | -28.57 | -77.24 | -92.85 | -25.7 |
| % Growth | 63% | 16.8% | -261.3% | – |
| Operating Cash Flow | -¥1,432,005 | -¥2,254,466 | -¥1,895,773 | -¥747,466 |
| Capital Expenditures | -¥188 | -¥39,699 | -¥197,287 | -¥107,111 |
| Free Cash Flow | -¥1,432,193 | -¥2,294,165 | -¥2,093,060 | -¥854,577 |